{"slug":"ret","tag":"ret","variants":["ret"],"description":"No description yet","count":1,"kinds":{"person":1},"related":[{"slug":"targeted-therapy","tag":"targeted-therapy","shared":1},{"slug":"thyroid","tag":"thyroid","shared":1}],"records":[{"id":"lori-wirth","kind":"person","name":"Lori J. Wirth","route":"/people/lori-wirth/","tldr":"Led LIBRETTO-001 in thyroid cancer, which made selpercatinib the first RET-selective drug approved for RET-driven tumours."}]}